Intervention Review

You have free access to this content

Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour

  1. Shanshan Han1,
  2. Caroline A Crowther1,*,
  3. Vivienne Moore2

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 31 MAY 2013

Assessed as up-to-date: 14 FEB 2013

DOI: 10.1002/14651858.CD000940.pub3


How to Cite

Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD000940. DOI: 10.1002/14651858.CD000940.pub3.

Author Information

  1. 1

    The University of Adelaide, ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology, Adelaide, South Australia, Australia

  2. 2

    University of Adelaide, Department of Public Health, Adelaide, South Australia, Australia

*Caroline A Crowther, ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology, The University of Adelaide, Women's and Children's Hospital, 72 King William Road, Adelaide, South Australia, 5006, Australia. caroline.crowther@adelaide.edu.au.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 31 MAY 2013

SEARCH

[Figure 1]
Figure 1. 'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
[Figure 2]
Figure 2. 'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Magnesium versus placebo or no treatment, Outcome 1 Preterm birth.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Magnesium versus placebo or no treatment, Outcome 2 Perinatal mortality.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Magnesium versus placebo or no treatment, Outcome 3 Maternal readmission for threatened preterm labour.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Magnesium versus placebo or no treatment, Outcome 4 Respiratory distress syndrome.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Magnesium versus placebo or no treatment, Outcome 5 Periventricular haemorrhage.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Magnesium versus placebo or no treatment, Outcome 6 Neonatal intensive care unit admissions.
[Analysis 1.7]
Analysis 1.7. Comparison 1 Magnesium versus placebo or no treatment, Outcome 7 Neonatal length of stay (days).
[Analysis 1.8]
Analysis 1.8. Comparison 1 Magnesium versus placebo or no treatment, Outcome 8 Gestational age at delivery (weeks).
[Analysis 1.9]
Analysis 1.9. Comparison 1 Magnesium versus placebo or no treatment, Outcome 9 Maternal side effects.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Magnesium versus alternative treatment, Outcome 1 Preterm birth.
[Analysis 2.2]
Analysis 2.2. Comparison 2 Magnesium versus alternative treatment, Outcome 2 Perinatal mortality.
[Analysis 2.3]
Analysis 2.3. Comparison 2 Magnesium versus alternative treatment, Outcome 3 Maternal readmission for threatened preterm labour.
[Analysis 2.4]
Analysis 2.4. Comparison 2 Magnesium versus alternative treatment, Outcome 4 Periventricular haemorrhage.
[Analysis 2.5]
Analysis 2.5. Comparison 2 Magnesium versus alternative treatment, Outcome 5 Neonatal intensive care unit admissions.
[Analysis 2.6]
Analysis 2.6. Comparison 2 Magnesium versus alternative treatment, Outcome 6 Neonatal length of stay (days).
[Analysis 2.7]
Analysis 2.7. Comparison 2 Magnesium versus alternative treatment, Outcome 7 Gestational age at delivery (weeks).
[Analysis 2.8]
Analysis 2.8. Comparison 2 Magnesium versus alternative treatment, Outcome 8 Maternal side effects.